• Accelerating TB vaccine Research & Development through partnership
  • TBVI TBVI TBVI
    • Home
    • About us
      • TBVI at a glance
      • Mission
      • Organisation
        • Governance Board
        • Advisory Committee
        • Steering Committee
        • Operational Office
        • Product and Clinical Development Team
        • Portfolio Management Committee
      • TBVI consortium
      • Key achievements and impact
      • Financials
    • What we do
      • Pipeline of vaccines
      • Research & Development
      • Services
    • How we work
      • Business model
      • Partnership
    • For partners
      • For researchers and vaccine developers
        • Partners pages
        • Access to services
      • MTBVAC in Newborns
        • Coordinator and partners
        • News and Publications
        • Communication tools
      • MTBVACN3
      • TBVAC2020
        • Word from the chair
        • TBVAC2020 project overview and achievements
        • TBVAC2020 project members
        • TBVAC2020 scientific publications
        • TBVAC2020 other publications
      • For funders
        • TBVI R&D priorities and funding opportunities
        • TBVI service provision and funding opportunities
        • Why invest in TBVI
    • News
    • Contact us:

    Archives

    Monthly Archive for: "January, 2015"
    Home / 2015 / January
      0
    By Cora Agterdenbosch
    In News Posted January 28, 2015

    New TBVI senior leadership

    The Governance Board of TBVI is pleased to announce the following senior leadership appointments:  The Executive Director of TBVI is Dr Nick Drager, previously Chair of the TBVI Advisory [...]

    Read More
      0
    By Cora Agterdenbosch
    In News Posted January 28, 2015

    24.6 million Euros for TB vaccine R&D

    The TBVI consortium has been granted 24.6 million euros  from the European Commission H2020 framework programme (€18.2 mln.) and several institutions as well as national governments outside the [...]

    Read More
      0
    By Cora Agterdenbosch
    In News Posted January 5, 2015

    New training on adjuvants and vaccine formulation, deadline for submission 28 Feb

    TBVI is partner in ADITEC, a project to advance new immunisation technologies. Partners of this consortium are presenting the fourth course on adjuvants and vaccine formulation. Dates: 15-19 June [...]

    Read More
    Load More
    Menu
    • Home
    • About us
    • What we do
    • How we work
    • For researchers and vaccine developers
    • For funders
    • Pipeline of vaccines
    • News
    TuBerculosis Vaccine Initiative (TBVI)

    Runderweg 6
    8219 PK Lelystad
    The Netherlands
    Email: info@tbvi.eu
    Phone: +31 320 277 550

    © 2015 TuBerculosis Vaccine Initiative (TBVI) | ALL RIGHTS RESERVED | Disclaimer | Sitemap | Door Internetbureau Redkiwi

    Start typing and press Enter to search

    Cookies

    This website uses cookies that help the website function

    OK No